Hims & Hers Health Inc. diskutieren
Hims & Hers Health Inc.
WKN: A2QMYY / Symbol: HIMS / Name: Hims & Hers Health / Aktie / ? /
31,70 €
-2,18 %
Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at TD Cowen. They now have a $28.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $42.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Needham & Company LLC from $28.00 to $31.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) is now covered by analysts at BTIG Research. They set a "buy" rating and a $35.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $25.00 price target on the stock, up previously from $24.00.
Ratings data for HIMS provided by MarketBeat
Der Beitrag wird untersucht
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $18.00 to $21.00. They now have an "underperform" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Citigroup Inc. from $25.00 to $27.00. They now have a "sell" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Needham & Company LLC from $31.00 to $61.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) had its "sell" rating re-affirmed by analysts at Citigroup Inc.. They now have a $27.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) had its "underperform" rating re-affirmed by analysts at Bank of America Co.. They now have a $21.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) had its "sell" rating re-affirmed by analysts at Citigroup Inc..
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target lowered by analysts at Citigroup Inc. from $27.00 to $25.00. They now have a "sell" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Bank of America Co. from $22.00 to $26.00. They now have an "underperform" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) had its "sell" rating re-affirmed by analysts at Citigroup Inc..
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $61.00 price target on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) had its price target raised by analysts at Needham & Company LLC from $61.00 to $65.00. They now have a "buy" rating on the stock.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) had its "underperform" rating re-affirmed by analysts at UBS Group AG.
Ratings data for HIMS provided by MarketBeat
Hims & Hers Health, Inc. (NYSE: HIMS) had its "sell" rating re-affirmed by analysts at Citigroup Inc..
Ratings data for HIMS provided by MarketBeat
Neueste Beiträge
Roth_Capital in Gran Tierra Energy Inc. diskutieren